Literature DB >> 19219654

DNA copy number variation and gene expression analyses reveal the implication of specific oncogenes and genes in GBM.

Javier Margareto1, Olatz Leis, Eider Larrarte, Iñigo C Pomposo, Jesus María Garibi, José Vicente Lafuente.   

Abstract

To understand the pathogenesis of glioblastoma multiforme (GBM) we used high-resolution comparative genomic hybridization arrays and gene expression microarrays to identify DNA copy number alterations and gene expression changes in comparable sets of GBM samples. Gains were detected at chromosomes 1, 2, 7, 9, 12, 19, and 20 and losses at 6, 9, and 10. Gene expression analyses identified specific genes overexpressed in GBM mapping at amplified chromosomal regions. Among these genes we found genes involved in angiogenesis, extracellular matrix remodeling and several oncogenes. DNA copy number analysis along with gene expression profiles provides a powerful strategy to understand tumor progression and identification of genes involved in GBM pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19219654     DOI: 10.1080/07357900802563044

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  10 in total

1.  The application of gene co-expression network reconstruction based on CNVs and gene expression microarray data in breast cancer.

Authors:  Yan Xu; Huizi Duanmu; Zhiqiang Chang; Shanzhen Zhang; Zhenqi Li; Zihui Li; Yufeng Liu; Kening Li; Fujun Qiu; Xia Li
Journal:  Mol Biol Rep       Date:  2011-05-25       Impact factor: 2.316

2.  Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.

Authors:  Basavaraj Vastrad; Chanabasayya Vastrad; Ashok Godavarthi; Raghu Chandrashekar
Journal:  Med Oncol       Date:  2017-09-26       Impact factor: 3.064

Review 3.  The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer.

Authors:  Douglas K Graham; Deborah DeRyckere; Kurtis D Davies; H Shelton Earp
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

4.  TAM receptors in leukemia: expression, signaling, and therapeutic implications.

Authors:  Luis Brandão; Justine Migdall-Wilson; Kristen Eisenman; Douglas K Graham
Journal:  Crit Rev Oncog       Date:  2011

Review 5.  Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Expert Opin Ther Targets       Date:  2010-10       Impact factor: 6.902

6.  Genome-wide identification of copy number variations in Chinese Holstein.

Authors:  Li Jiang; Jicai Jiang; Jiying Wang; Xiangdong Ding; Jianfeng Liu; Qin Zhang
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

7.  KDM4C Activity Modulates Cell Proliferation and Chromosome Segregation in Triple-Negative Breast Cancer.

Authors:  Jeison Garcia; Fernando Lizcano
Journal:  Breast Cancer (Auckl)       Date:  2016-11-02

8.  Multi-platform whole-genome microarray analyses refine the epigenetic signature of breast cancer metastasis with gene expression and copy number.

Authors:  Joseph Andrews; Wendy Kennette; Jenna Pilon; Alexandra Hodgson; Alan B Tuck; Ann F Chambers; David I Rodenhiser
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

9.  Genome-wide detection of copy number variations using high-density SNP genotyping platforms in Holsteins.

Authors:  Li Jiang; Jicai Jiang; Jie Yang; Xuan Liu; Jiying Wang; Haifei Wang; Xiangdong Ding; Jianfeng Liu; Qin Zhang
Journal:  BMC Genomics       Date:  2013-02-27       Impact factor: 3.969

10.  Epigenetic control and cancer: the potential of histone demethylases as therapeutic targets.

Authors:  Fernando Lizcano; Jeison Garcia
Journal:  Pharmaceuticals (Basel)       Date:  2012-09-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.